MeVa-Study (Medulloblastoma analysis of cerebro-vascular subsequent damage following radio-chemo-therapy).
Laufzeit: 01.01.2015 - 31.12.2017
Kurzfassung
Follow-up-study of patients suffering from medulloblastoma in the years 1960-2015 (n=61, age: 0-60y) with finished therapy as well as actual therapy at the beginning of the study (June 2015). The main investigator is Univ.-Prof. Dr. Faber head of the center of pediatric oncology at the University childrens hospital in Mainz. The neuroradiological part is the MR-examination and evaluation of the cranio-spinal axis with emphasis of the development of cerebrovascular diseases (i.e....Follow-up-study of patients suffering from medulloblastoma in the years 1960-2015 (n=61, age: 0-60y) with finished therapy as well as actual therapy at the beginning of the study (June 2015). The main investigator is Univ.-Prof. Dr. Faber head of the center of pediatric oncology at the University childrens hospital in Mainz. The neuroradiological part is the MR-examination and evaluation of the cranio-spinal axis with emphasis of the development of cerebrovascular diseases (i.e. infarction, narrowing of cerebral vessels) and/or cerebrovascular malformation especially cavernoma.» weiterlesen» einklappen